A case of Ménétrier's disease localized to the gastric antrum without helicobacter infection or hypoalbuminemia  by Sweeney, Adam R. & Lynch, Maureen K.
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INTRODUCTION:  Ménétrier’s  disease  (MD)  is  a  rare gastric  disorder  closely  associated  with  Helicobacter
pylori  infection  characterized  by  enlarged  gastric  mucosal  folds  and  hyperplasia  of surface  mucus-
secreting  cells  classically  localized  to the  gastric  body.  This  disease  has  signiﬁcant  morbidity  and  mortality
secondary  to hypoproteinemia,  gastric  obstruction,  hemorrhage,  and  increased  risk  of  adenocarcinoma.
PRESENTATION OF  CASE:  We  report  a 53-year-old  female  who  presented  with  severe  epigastric  pain,
anorexia,  weight  loss, and  prandial  vomiting  with  serum  albumin  and  chloride  levels in  the  normal  range.
After  serial  upper  endoscopy  with  biopsy  identiﬁed  nonspeciﬁc  inﬂammatory  changes  in  the  absence  of
H.  pylori,  surgical  exploration  was  performed  with  intraoperative  tissue  samples  revealing  nondysplas-
tic,  foveolar  hyperplasia.  Gastric  antrectomy  was  performed  with  gross  and  microscopic  examinationypoalbuminemia
elicobacter  pylori
verifying  the  diagnosis  of  MD.
DISCUSSION: The  unusual  presentation  of  this  case  differentiates  it from  other  known  cases  due to the
rare  localization  of the disease  to  the  gastric  antrum,  the  absence  of H. pylori  infection,  and  the  unchar-
acteristically  normal  serum  albumin  level  on presentation.
CONCLUSION: This  case  may  represent  an  unreported  subset  of  MD  where  limited  surgical  resection  is
 exce
013 T  demonstrated  to offer an
© 2
. Introduction
Ménétrier’s disease, also referred to as protein-losing hyper-
rophic gastropathy, is a rare condition affecting mostly middle-
ged males characterized by hypoproteinemia, hypochloremia,
onsiderable gastric hypertrophy, and increased risk of gastric ade-
ocarcinoma. The etiology of MD  is largely unknown, but recently
t has been shown that an upregulation of TGF- binding to gastric
pidermal growth factor receptor (EGF-R) is associated with MD1
nd may  be the underlying cause of most, if not all, of the cellular
hanges.
Histologically, this disease is characterized by hyperplasia of
he resident mucus-secreting surface cells found in the gastric pits,
alled foveolar epithelium, which replace much of the normal glan-
ular architecture. These changes are overwhelmingly localized to
he gastric body, with close association to colonization of this area
ith Helicobacter pylori, which normally has a preference for the
astric antrum.
∗ Corresponding author. Tel.: +1 2088597375; fax: +1 2084531538.
E-mail  address: asweeney@uw.edu (A.R. Sweeney).
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The classic clinical presentation of MD includes epigastric pain,
non-dependent edema, and signs of chronic obstruction—notably
nausea, vomiting, anorexia, and weight loss. The diagnosis is rarely
made from presentation alone and requires an appropriate workup
including serum albumin levels, upper endoscopy, and biopsy with
staining for H. pylori.
Without  adequate therapy, this disease has signiﬁcant morbid-
ity and mortality secondary to gastric obstruction, hemorrhage,
progression to cancer, and loss of protein through increased gas-
tric mucosal permeability. Treatment for this rare disease is poorly
understood and requires a careful review of the literature where
several therapeutic options are explored including H. pylori eradica-
tion, somatostatin analog injections, monoclonal antibody therapy,
or total/near-total gastric resection.
2. Presentation of case
A  53 year old postmenopausal female with an uncomplicated
medical history presented with a four-week history of worsening
epigastric pain, bloating, early satiety, and vomiting with intake
of solids or liquids resulting in an 18-pound weight loss since
symptom onset. With suspected peptic ulcer disease, an esoph-
agogastroduodenoscopy (EGD) was performed with ﬁndings of
Open access under CC BY license.thickened folds and discontinuous inﬂammatory tissue (Fig. 1).
Numerous tissue fragments were obtained for biopsy, which
revealed non-malignant, surface epithelial erosion and reactive
epithelial changes. The tissues sampled were carefully examined
s Ltd. Open access under CC BY license.
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eig. 1. EGD of the distal stomach showing markedly thickened gastric folds, ery-
hema, and nodularity involving the gastric antrum.
or H. pylori with no ﬁndings of the organism. Following a pre-
ipitant return to the emergency department with worsening
ymptoms, abdominal CT with IV contrast identiﬁed gastric wall
hickening with no associated gastric mass or adenopathy. A sub-
equent EGD was  performed where biopsied samples from various
egions of the stomach demonstrated chronic inﬂammation, ulcer-
tion and intramural microscopic abscesses localized in clusters
hroughout the antral mucosa. All samples were stained and care-
ully inspected for H. pylori with negative ﬁndings.
With an obscure clinical picture, a full surgical workup was
erformed where labs revealed normal gastrin and CEA tumor
arker levels with CBC, LDH, and LFT levels all within the normal
ange including an albumin of 3.90 g/dL. These labs essentially ruled
ut Zollinger-Ellison syndrome, lymphoma, and other suspected
astric malignancies. With worsening abdominal pain, nutritional
eprivation, and an unclear diagnosis, the patient was prepped for
n open surgical survey of the abdomen.
Surgical exploration revealed localized thickening and inﬂam-
atory changes over the surface of the gastric antrum extending
nto the lesser curvature and posterior gastric wall with marked
astric outlet obstruction. With no signs of inﬂammatory spread or
etastasis, the gastric antrum was resected with 1.0 cm margins.
ntraoperative biopsy of the resected tissue was sent to pathology
here microscopic examination revealed generalized thickening
f the muscular wall with areas of scant mucosal inﬂammation
mmediately transforming to areas with marked foveolar hyperpla-
ia, microulcerations, considerable submucosal edema and acute
nﬂammatory changes in the absence of signiﬁcant eosinophilia
Fig. 2). Both the proximal and distal margins of the resection
ere uninvolved. Careful inspection for dysplasia or H. pylori in
ll aspects of the resected tissue was performed with no associated
ndings.
With pathological reports that the antral resection contained
he localized disease process with negative margins, anastomosis
f the proximal gastric antrum and the duodenum was  performed
ithout complication.
The patient tolerated the procedure well and began introducingolid food into her diet on post-operative day ﬁve without difﬁculty.
he is now in full recovery and enjoying a normal diet with no
pigastric pain or signs of anastomotic leakage/obstruction.Fig. 2. Histology from a section of the gastric antrum revealed marked foveolar
hyperplasia involving the full thickness of the mucosa.
3. Discussion
This case differentiates itself from others due to the initially
normal serum albumin level, the localization of the gross and his-
tological changes to the gastric antrum, and the lack of H. pylori
colonization. This unusual presentation draws attention to the
diagnostic speciﬁcity of generally understood principles of the dis-
ease process, particularly the occurrence of H. pylori infection and
serum albumin levels.
H. pylori is closely associated with adult MD and has become
regarded by some as a precursor to the disease process.2,3 A
prominent case series investigating 138 patients with hypertrophic
gastropathy reported more than 90% of cases having biopsy proven
H. pylori infection.4 One hypothesis is that H.  pylori may  induce
COX-2 mediated down-regulation of apoptosis in the mucin-
secreting gastric cells allowing for hypertrophic changes and severe
protein and chloride secretion.5 A literature review reveals few
diagnoses of MD in the absence of H. pylori colonization to the
affected tissue. Considering the extent of tissue biopsied in this
case, great conﬁdence can be made in reporting the negative H.
pylori status. This offers evidence that H. pylori may  not be a pre-
cursor infection, but rather a possible contributing factor to the
development of foveolar hyperplasia and gastric hypertrophy.
Hypoalbuminemia is generally considered to be a deﬁning
lab ﬁnding for MD.  A case series studying a group of adults
diagnosed with MD  reported a mean serum albumin of 1.8 g/dL
(range 1.5–2.5 g/dL) with coexisting edema present in 50% of those
studied.6 In this case, the patient had a serum albumin level of
3.9 g/dL and no edema. It was  not until the patient was recov-
ering from surgery that she developed hypoalbuminemia with a
trough of 2.6 g/dL. The author believes that the coinciding hypoal-
buminemia correlates to prior starvation compounded with a
dilutional effect from extensive postoperative hydration, however,
it must be considered that this hypoalbuminemia may represent
delayed gastrointestinal protein loss in conjunction with the fea-
tures previously mentioned. Moreover, even with the consideration
of compounding factors, the serum albumin trough in this case
was higher than the range reported, offering speculation that the
pathology was discovered earlier than most reported cases or that
this may  be a novel subtype of hypertrophic gastropathy.
Treatment for MD  is largely divided into schemas that target
eradication of H. pylori with antisecretory and antibiotic therapy,
modulation of the TGF-/EGF-R signal cascade with the somato-
statin analog ocreotide, EGF receptor-binding monoclonal antibody
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herapy, or surgical resection. Several studies have been aimed at
reating the disease with antisecretory and antimicrobial combi-
ation therapy with positive ﬁndings,3,7 yet in the condition of H.
ylori negative MD,  one might expect the disease to be refractory to
his combination therapy. Anecdotal evidence for ocreotide therapy
as been largely aimed at alleviating symptoms associated with the
isease,8,9 but does not address the concerns for disease progres-
ion and gastric adenocarcinoma. Monoclonal antibody therapy
argeting EGF receptors has shown promising results for chronic
ases,10 however, surgical resection is the preferred treatment for
ases refractory to medical management, acute clinical decline,
nd for prophylaxis against gastric adenocarcinoma. To date, the
tandard surgical treatment for MD  is total to near-total gastrec-
omy with the use of laparoscopic technique recently pioneered.11
otal gastrectomy has largely been performed despite the char-
cteristic antral sparing in MD  due to concern for postoperative
eakage after anastomosis of inﬂamed tissue. To the author’s knowl-
dge, no research has been done to analyze the success of limited
astric resection in cases of MD  localized to the gastric antrum. This
ase report, however, demonstrates that in such circumstances,
he inﬂammation may  be well circumscribed, potentially allow-
ng diminished rates of complication from anastomotic leakage and
verall improved success with limited gastric resection.
In cases of MD,  it is unknown whether limited gastrectomy
ill inﬂuence the rate of impending gastric adenocarcinoma. It is
onceivable, nevertheless, that resection of all affected tissue in a
ell-localized disease will dramatically decrease the risk for dys-
lastic events. This should be considered when evaluating potential
herapies for patients with MD.
. Conclusion
This case may  represent a subtype of MD that presents in the
dult gastric antrum without H. pylori infection or initial hypoalbu-
inemia, mimicking advanced ulcerative disease with nutritional
epletion and nonspeciﬁc pathological ﬁndings.
Considering that H. pylori generally colonizes the gastric body
n MD  localized to this region, H. pylori negative MD  may  have a
igher rate of antral involvement.Suspicion should be raised with acute gastric obstruction and
ndings on upper endoscopy of enlarged gastric folds despite H.
ylori status for a possible new subtype of MD  where limited sur-
ical resection with negative margins may  offer the best outcome.
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